A Population-based Cohort in Northern Spain

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age40-69
SponsorInstituto de Investigación Marqués de Valdecilla

About this trial

Cantabria Cohort stems from a research and action initiative lead by researchers from Valdecilla Research Institute (IDIVAL), Marqués de Valdecilla University Hospital and University of Cantabria, supported by the regional Goverment. Its aim is to identify and follow up a cohort that would provide information to improve the understanding of the etiology and prognosis of different acute and chronic diseases. The Cantabria Cohort will recruit between 40,000-50,000 residents aged 40-69 years at baseline, representing 10-20% of the target population. Currently, more than 22,000 volunteers have been enrolled. All participants will be invited for a re-assessment every three years, while the overall duration is planned for twenty years. The repeated collection of biomaterials combined with broad information from participant questionnaires, medical examinations, actual health system records and other secondary public data sources is a major strength of its design, which will make it possible to address biological pathways of disease development, identify new factors involved in health and disease, design new strategies for disease prevention, and advance precision medicine. It is conceived to allow access to a large number of researchers worldwide to boost collaboration and medical research.

Eligibility criteria

Qualifiers

Participants between 40-69 years of age

Participants who sign the informed consent form

Participants legally residing in Cantabria

Disqualifiers

Participants under 40 years of age and over 69 years of age

Participants not signing the informed consent form

Participants not legally residing in Cantabria

Trial design

Treatments tested in this trial

  • cohort

Treatment groups

22,000 Participants
are divided into 1 treatment group